Effective with dates of service beginning May 1, 2014, WSI will adopt the guidelines highlighted below in the auditing of Evaluation and Management (E/M) documentation.
WSI does not cover H-wave electrical stimulation, as it is investigational and experimental.
form, Post Injection Pain Response Note, is available for providers to document response to an injection.
Facilities should use the WSI specific procedure code, W0555, when billing for Independent Exercise Program (IEP).
WSI has identified healthcare providers billing services to Medicare when WSI is the primary payer.
The following information provides clarification on reimbursement and prior authorization for hearing aids and associated services.
Effective October 1, 2013, WSI will no longer approve new requests for use of the continuous-flow cryotherapy units, e.g. Game Ready™ Accelerated Recovery System.
In January 2013, WSI issued a Provider Bulletin detailing criteria for the workability assessment program.
On November 1, 2013, WSI will utilize PMSI® d.b.a. tmesys®, to provide the same point-of-sale transactions currently in place with US Script®.
Bloodborne pathogen exposure claims need to be billed with modifier 22 added to the charges for the source patient.
On April 17, 2013 Oxycontin was scheduled to go off the patent protection and become available for the generic marketplace.